{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:57:47Z","timestamp":1794351467683,"version":"4.9.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/pas.0000000000000471","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T11:49:34Z","timestamp":1435837774000},"page":"1411-1419","source":"Crossref","is-referenced-by-count":149,"title":["GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract"],"prefix":"10.1097","volume":"39","author":[{"given":"Brooke E.","family":"Howitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Emori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine A.","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210131","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1084\/jem.20090934","article-title":". GATA-3 is required for early T lineage progenitor development.","volume":"206","author":"Hosoya","year":"2009","journal-title":"J Exp Med"},{"key":"R2-15-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.21943","article-title":"GATA3 in development and cancer differentiation: cells GATA have it!.","volume":"222","author":"Chou","year":"2010","journal-title":"J Cell Physiol"},{"key":"R3-15-20210131","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2011-07-366070","article-title":". GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry.","volume":"119","author":"Ku","year":"2012","journal-title":"Blood"},{"key":"R4-15-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ydbio.2013.07.028","article-title":". A core transcriptional network composed of Pax28, Gata3 and Lim1 regulates key players of promesonephros morphogenesis.","volume":"382","author":"Boualia","year":"2013","journal-title":"Dev Biol"},{"key":"R5-15-20210131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng0995-40","article-title":". Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis.","volume":"11","author":"Pandolfi","year":"1995","journal-title":"Nat Genet"},{"key":"R6-15-20210131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/35019088","article-title":". GATA3 haplo-insufficiency causes human HDR syndrome.","volume":"406","author":"Van Esch","year":"2000","journal-title":"Nature"},{"key":"R7-15-20210131","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2009-0717","article-title":". A missense GATA3 mutation, Thr272Ile, causes the hypoparathyroidism, deafness, and renal dysplasia syndrome.","volume":"94","author":"Gaynor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-15-20210131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1242\/dev.02184","article-title":". Pax28-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney.","volume":"133","author":"Grote","year":"2006","journal-title":"Development"},{"key":"R9-15-20210131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.pas.0000213438.01278.5f","article-title":". Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.","volume":"31","author":"Higgins","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R10-15-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":". Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R11-15-20210131","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":". GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.","volume":"44","author":"Cimino-Mathews","year":"2013","journal-title":"Hum Pathol"},{"key":"R12-15-20210131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review.","volume":"20","author":"Ordonez","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R13-15-20210131","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAI.0000000000000007","article-title":"Value of GATA3 immunostaining in the diagnosis of parathyroid tumors.","volume":"22","author":"Ordonez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-15-20210131","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.humpath.2014.02.024","article-title":". Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.","volume":"45","author":"Paner","year":"2014","journal-title":"Hum Pathol"},{"key":"R15-15-20210131","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","article-title":". Differential expression of GATA-3 in urothelial carcinoma variants.","volume":"45","author":"Liang","year":"2014","journal-title":"Hum Pathol"},{"key":"R16-15-20210131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/PAS.0b013e3181908e24","article-title":". Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.","volume":"33","author":"Esheba","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R17-15-20210131","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/PAS.0b013e318289c765","article-title":". A study of Gata3 and Phox2b expression in tumors of the autonomic nervous system.","volume":"37","author":"Nonaka","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R18-15-20210131","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e318260cde7","article-title":". Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R19-15-20210131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-013-0442-3","article-title":". GATA3 immunohistochemical expression in salivary gland neoplasms.","volume":"7","author":"Schwartz","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R20-15-20210131","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.humpath.2013.07.006","article-title":". The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.","volume":"44","author":"Gonzalez-Roibon","year":"2013","journal-title":"Hum Pathol"},{"key":"R21-15-20210131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.humpath.2013.08.020","article-title":". Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.","volume":"45","author":"Gonzalez-Roibon","year":"2014","journal-title":"Hum Pathol"},{"key":"R22-15-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":". GATA3: a multispecific but potentially useful marker in surgical pathology.","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R23-15-20210131","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/ki.1995.223","article-title":". The GATA-3 gene is expressed during human kidney embryogenesis.","volume":"47","author":"Labastie","year":"1995","journal-title":"Kidney Int"},{"key":"R24-15-20210131","doi-asserted-by":"crossref","first-page":"e1000316","DOI":"10.1371\/journal.pgen.1000316","article-title":". Gata3 acts downstream of beta-catenin signaling to prevent ectopic metanephric kidney induction.","volume":"4","author":"Grote","year":"2008","journal-title":"PLoS Genet"},{"key":"R25-15-20210131","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R26-15-20210131","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R27-15-20210131","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00000478-199510000-00006","article-title":". Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.","volume":"19","author":"Clement","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R28-15-20210131","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5858\/arpa.2012-0493-RA","article-title":"The spectrum of cervical glandular neoplasia and issues in differential diagnosis.","volume":"138","author":"Loureiro","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R29-15-20210131","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/00000478-200308000-00005","article-title":"Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.","volume":"27","author":"Tambouret","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R30-15-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":". CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors.","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R31-15-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":". CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R32-15-20210131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000478-200405000-00006","article-title":"Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.","volume":"28","author":"Bague","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R33-15-20210131","first-page":"7012","article-title":". Mesonephric adenocarcinoma of the uterine corpus.","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R34-15-20210131","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":". Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R35-15-20210131","first-page":"310","article-title":"CD10 expression in the female genital tract: does it have useful diagnostic applications Adv Anat Pathol.","volume":"11","author":"Oliva","year":"2004","journal-title":""},{"key":"R36-15-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/00313020601123961","article-title":"Immunohistochemistry as a diagnostic aid in cervical pathology.","volume":"39","author":"McCluggage","year":"2007","journal-title":"Pathology"},{"key":"R37-15-20210131","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ygyno.2009.10.055","article-title":". A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.","volume":"116","author":"Pavlakis","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R38-15-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/PAS.0b013e3181c89c98","article-title":". PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.","volume":"34","author":"Rabban","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R39-15-20210131","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":". Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-.","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R40-15-20210131","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/PGP.0000000000000102","article-title":"Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.","volume":"33","author":"Goyal","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R41-15-20210131","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.prp.2008.01.008","article-title":"Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies.","volume":"204","author":"Fukunaga","year":"2008","journal-title":"Pathol Res Pract"},{"key":"R42-15-20210131","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/his.12546","article-title":"Adenomyomas of the uterine cervix: report of a case series of endocervical type and the first report of a mesonephric adenomyoma cohort including endocervical and novel variants.","volume":"66","author":"Casey","year":"2015","journal-title":"Histopathology"},{"key":"R43-15-20210131","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R44-15-20210131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":". PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R45-15-20210131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":". A comprehensive analysis of PAX8 expression in human epithelial tumors.","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R46-15-20210131","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":". PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R47-15-20210131","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/PAS.0b013e31822d787c","article-title":". PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison.","volume":"35","author":"Ozcan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R48-15-20210131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/PGP.0b013e31821ac6c3","article-title":". Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53.","volume":"30","author":"Brunner","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R49-15-20210131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13039-014-0085-4","article-title":". A de novo 10.79 Mb interstitial deletion at 2q13q14.2 involving PAX8 causing hypothyroidism and mullerian agenesis: a novelcase report and literature review.","volume":"7","author":"Ma","year":"2014","journal-title":"Mol Cytogenet"},{"key":"R50-15-20210131","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/PAS.0b013e3182260735","article-title":"Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis.","volume":"35","author":"Weissferdt","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R51-15-20210131","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0b013e318227e2ee","article-title":". PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.","volume":"35","author":"Tong","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R52-15-20210131","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/PAS.0b013e318218df97","article-title":"Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.","volume":"35","author":"Chen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R53-15-20210131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/dbio.2000.9971","article-title":". Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives.","volume":"229","author":"Kuschert","year":"2001","journal-title":"Dev Biol"},{"key":"R54-15-20210131","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.humpath.2010.01.010","article-title":". The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.","volume":"41","author":"Quick","year":"2010","journal-title":"Hum Pathol"},{"key":"R55-15-20210131","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":". High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.","volume":"23","author":"Roh","year":"2010","journal-title":"Mod Pathol"},{"key":"R56-15-20210131","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":". Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"R57-15-20210131","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PGP.0b013e318166067f","article-title":"Mesonephric adenocarcinoma of the uterine corpus: a case report and review of the literature.","volume":"27","author":"Wani","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R58-15-20210131","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","article-title":". Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.","volume":"35","author":"Park","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R59-15-20210131","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","article-title":"IeM Shih, et al.. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R60-15-20210131","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0002-9440(10)61143-1","article-title":". Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis.","volume":"160","author":"Steenbergen","year":"2002","journal-title":"Am J Pathol"},{"key":"R61-15-20210131","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2559.2010.03632.x","article-title":". p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.","volume":"57","author":"Houghton","year":"2010","journal-title":"Histopathology"},{"key":"R62-15-20210131","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/PGP.0000000000000139","article-title":"Pseudoneoplastic glandular lesions of the uterine cervix: a selective review.","volume":"33","author":"Nucci","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R63-15-20210131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00404-009-1264-0","article-title":". Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature.","volume":"281","author":"Bogliolo","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"R64-15-20210131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PAS.0b013e3181d6b8fd","article-title":"Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases.","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R65-15-20210131","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/PAS.0b013e318251eade","article-title":". Urothelial carcinoma involving the gynecologic tract: a morphologic and immunohistochemical study of 6 cases.","volume":"36","author":"Reyes","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R66-15-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00428-013-1436-y","article-title":". Secondary malignancies of the uterine cervix: a potential diagnostic pitfall.","volume":"463","author":"Zannoni","year":"2013","journal-title":"Virchows Arch"},{"key":"R67-15-20210131","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0046-8177(99)90148-X","article-title":"Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin.","volume":"30","author":"Devouassoux-Shisheboran","year":"1999","journal-title":"Hum Pathol"},{"key":"R68-15-20210131","first-page":"656","article-title":". Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.","volume":"11","author":"Kommoss","year":"1998","journal-title":"Mod Pathol"},{"key":"R69-15-20210131","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/dvdy.22640","article-title":". Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules.","volume":"240","author":"Georgas","year":"2011","journal-title":"Dev Dyn"},{"key":"R70-15-20210131","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.mod.2013.07.006","article-title":"Pkd1 is required for male reproductive tract development.","volume":"130","author":"Nie","year":"2013","journal-title":"Mech Dev"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:15Z","timestamp":1620967515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201510000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000471","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}